Stem Cell Therapy for Myocardial Infarction 2001–2013 Revisited

[1]  J. Vicencio,et al.  Plasma exosomes protect the myocardium from ischemia-reperfusion injury. , 2015, Journal of the American College of Cardiology.

[2]  D. Atsma,et al.  Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data. , 2015, Circulation research.

[3]  B. Gersh,et al.  Cell therapy for human ischemic heart diseases: critical review and summary of the clinical experiences. , 2014, Journal of molecular and cellular cardiology.

[4]  D. Groneberg,et al.  MRSA: A Density-Equalizing Mapping Analysis of the Global Research Architecture , 2014, International journal of environmental research and public health.

[5]  T. Moccetti,et al.  Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction. , 2014, Cardiovascular research.

[6]  Derek Bell,et al.  Using geographical information systems and cartograms as a health service quality improvement tool. , 2014, Spatial and spatio-temporal epidemiology.

[7]  Darrel P. Francis,et al.  2014 Global geographic analysis of mortality from ischaemic heart disease by country, age and income: Statistics from World Health Organisation and United Nations , 2014, International journal of cardiology.

[8]  A. Zeiher,et al.  Long-term clinical outcome after intracoronary application of bone marrow-derived mononuclear cells for acute myocardial infarction: migratory capacity of administered cells determines event-free survival. , 2014, European heart journal.

[9]  E. Marbán,et al.  Exosomes as Critical Agents of Cardiac Regeneration Triggered by Cell Therapy , 2014, Stem cell reports.

[10]  D. Groneberg,et al.  Influenza: a scientometric and density-equalizing analysis , 2013, BMC Infectious Diseases.

[11]  P. Anversa,et al.  Stem cells: Bone-marrow-derived cells and heart failure—the debate goes on , 2013, Nature Reviews Cardiology.

[12]  P. Doevendans,et al.  Stem cells for cardiac repair: an introduction , 2013, Journal of geriatric cardiology : JGC.

[13]  R. Vasan,et al.  Circulating CD34(+) progenitor cell frequency is associated with clinical and genetic factors. , 2013, Blood.

[14]  M. Mildner,et al.  Secretome of apoptotic peripheral blood cells (APOSEC) confers cytoprotection to cardiomyocytes and inhibits tissue remodelling after acute myocardial infarction: a preclinical study , 2011, Basic Research in Cardiology.

[15]  A. Zeiher,et al.  Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy , 2011, Clinical Research in Cardiology.

[16]  M. Mildner,et al.  Intravenous and intramyocardial injection of apoptotic white blood cell suspensions prevents ventricular remodelling by increasing elastin expression in cardiac scar tissue after myocardial infarction , 2011, Basic Research in Cardiology.

[17]  C. Scutaru,et al.  Critical analysis of publication prozedures and evaluation regarding ankylosing spondylitis by density-equalizing mapping and scientometeric methods , 2010, Scandinavian journal of rheumatology.

[18]  H. Ly,et al.  The Paracrine Effect: Pivotal Mechanism in Cell-Based Cardiac Repair , 2010, Journal of cardiovascular translational research.

[19]  Gerard Pasterkamp,et al.  Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. , 2010, Stem cell research.

[20]  A. Ganser,et al.  Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial. , 2009, European heart journal.

[21]  S. Mache,et al.  Scoliosis: density-equalizing mapping and scientometric analysis , 2009, Scoliosis.

[22]  B. Russell,et al.  Stem Cell Therapy for Cardiac Repair , 2009, The Journal of cardiovascular nursing.

[23]  H. Figulla,et al.  Endothelial progenitor cells in adolescents: impact of overweight, age, smoking, sport and cytokines in younger age , 2009, Clinical Research in Cardiology.

[24]  A. Ganser,et al.  Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction. , 2008, European heart journal.

[25]  Michael J Pencina,et al.  Long-Term Trends in the Incidence of Heart Failure After Myocardial Infarction , 2008, Circulation.

[26]  E. Andreu,et al.  Characterization of the paracrine effects of human skeletal myoblasts transplanted in infarcted myocardium , 2008, European journal of heart failure.

[27]  X. Ren,et al.  Paracrine action of HO‐1‐modified mesenchymal stem cells mediates cardiac protection and functional improvement , 2008, Cell biology international.

[28]  C. Scutaru,et al.  Journal of Occupational Medicine and Toxicology Models of Asthma: Density-equalizing Mapping and Output Benchmarking , 2022 .

[29]  H. Haider,et al.  Pharmacologically Preconditioned Skeletal Myoblasts Are Resistant to Oxidative Stress and Promote Angiomyogenesis via Release of Paracrine Factors in the Infarcted Heart , 2007, Circulation research.

[30]  A. Zeiher,et al.  Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction. , 2007, European heart journal.

[31]  E. Taraldsrud,et al.  Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. , 2006, The New England journal of medicine.

[32]  A. Zeiher,et al.  Transcoronary transplantation of progenitor cells after myocardial infarction. , 2006, The New England journal of medicine.

[33]  A. Zeiher,et al.  Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. , 2006, The New England journal of medicine.

[34]  Joshua M. Hare,et al.  Is stem cell therapy ready for patients? Stem Cell Therapy for Cardiac Repair. Ready for the Next Step . , 2006, Circulation.

[35]  M. Ashraf,et al.  Bone Marrow Stem Cells Prevent Left Ventricular Remodeling of Ischemic Heart Through Paracrine Signaling , 2006, Circulation research.

[36]  X. Qin,et al.  Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction. , 2005, The Annals of thoracic surgery.

[37]  I. Weissman,et al.  Stimulation of Paracrine Pathways With Growth Factors Enhances Embryonic Stem Cell Engraftment and Host-Specific Differentiation in the Heart After Ischemic Myocardial Injury , 2005, Circulation.

[38]  J. Ingwall,et al.  Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells , 2005, Nature Medicine.

[39]  W. Hofmann,et al.  Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. , 2004, Journal of the American College of Cardiology.

[40]  Bernd Hertenstein,et al.  Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial , 2004, The Lancet.

[41]  Michael T. Gastner,et al.  From The Cover: Diffusion-based method for producing density-equalizing maps. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[42]  A. Zeiher,et al.  Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI) , 2002, Clinical research in cardiology : official journal of the German Cardiac Society.

[43]  E. Topol,et al.  Autologous cell transplantation for the treatment of damaged myocardium. , 2002, Progress in cardiovascular diseases.

[44]  David M. Bodine,et al.  Bone marrow cells regenerate infarcted myocardium , 2001, Nature.

[45]  S. Homma,et al.  Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function , 2001, Nature Medicine.

[46]  Z. Karabekian,et al.  Stem Cell Rev and Rep , 2010 .

[47]  R. Kloner,et al.  Role of a paracrine action of mesenchymal stem cells in the improvement of left ventricular function after coronary artery occlusion in rats. , 2007, Regenerative medicine.